Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-4.05

-2.94

-1.83

-0.73

Details

Expected EPS

-0.824333

Actual EPS

-1.36

Surprise EPS

-0.54

Surprise Percent

+64.98%

Description

Spyre Therapeutics (SYRE) has reported earnings of -1.36 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.